Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Roger Packer MD

Roger J. Packer MD

Senior Vice-President, Center for Neuroscience and Behavioral Medicine, Brain Tumor Institute, Gilbert Family Neurofibromatosis Institute, Children’s National Hospital, Washington, DC

Dr. Roger J. Packer is Senior Vice-President, Center for Neuroscience and Behavioral Medicine, the Gilbert Distinguished Professor of Neurofibromatosis, and Director of both the Gilbert Neurofibromatosis Institute and the Brain Tumor Institute of Children’s National Hospital (CNH), Washington, DC.  He is Professor of Neurology and Pediatrics at The George Washington University. 

Throughout his career, Dr. Packer has been heavily involved in clinical and applied basic science research.  His clinical research has touched on various aspects of child neurology and neuro-oncology, including pediatric brain tumors, neurofibromatosis type 1, and the neurologic aspects of childhood neurogenetic diseases. His research has focused on the development and performance of clinical and translational trials for children with neurologic, neuro-oncologic, and neurogenetic disorders, and he has received peer-reviewed grant support for these efforts. 

Presently, Dr. Packer is Chair of the PBTC Low-Grade Glioma Committee; Principal Investigator (CNH) of the Neurofibromatosis Clinical Trials Consortium; Chair of the Medulloblastoma Committee of the Children’s Oncology Group; and co-chair of the Brain Malignancy Steering Committee (NCI). The majority of the studies now being coordinated by Dr. Packer are evaluating innovative agents aimed at the molecular underpinnings and immunologic aspects of neurologic disease.  He has published over 415 original articles and 380 reviews and chapters.